Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOCCCA: G-CSF vs Chemo + G-CSF for Stem Cell Mobilization
NCT03442673Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Sep 2018
- Primary completion
- Mar 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in multiple myeloma (MM), amyloidosis, sponsored by Insel Gruppe. Started Sep 2018; status: completed.
02
Drugs
filgrastim
03
Conditions
multiple myeloma (MM)amyloidosis
Beyond the preview
Go deeper on NCT03442673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442673.